Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.

International journal of cancer - 15 Jan 2014

Wong-Brown Michelle W, Avery-Kiejda Kelly A, Bowden Nikola A, Scott Rodney J

Abstract excerpt

Triple-negative breast cancer (TNBC) is a tumour classification that is defined by oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 receptor negativity. TNBCs share a similar gene expression profile to BRCA-mutated tumours, have been shown to carry a high proportion of BRCA mutations and have a more adverse prognosis compared to other types of breast tumours. PALB2 has been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to BRCA2 Protein
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Lobular

Share to Carcinoma, Medullary

Share to Carcinoma, Papillary

Share to Fanconi Anemia Complementation Group N Protein

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 23824750
DOI: 10.1002/ijc.28361

Genes

PALB2
BRCA1
BRCA2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.PMID 23824750Read ↗

Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls.Semantic proximity Read ↗

Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.Semantic proximity Read ↗

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.Semantic proximity Read ↗

The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia.Semantic proximity Read ↗

Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.Semantic proximity Read ↗

PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China.Semantic proximity Read ↗

Characterisation of protein-truncating and missense variants in PALB2 in 15 768 women from Malaysia and Singapore.Semantic proximity Read ↗

Comprehensive sequencing of PALB2 in patients with breast cancer suggests PALB2 mutations explain a subset of hereditary breast cancer.Semantic proximity Read ↗

Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing.Semantic proximity Read ↗

Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.Semantic proximity Read ↗

Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore.Semantic proximity Read ↗

Spectrum and characteristics of germline PALB2 pathogenic variants in 1556 early-onset breast cancer patients in China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.